Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Hub Group, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Investors who purchased Hub Group securities may be entitled to compensation through a contingency fee arrangement, with a class action being prepared to recover investor losses [2]. - Interested investors can join the prospective class action by submitting a form or contacting the law firm directly [2]. Group 2: Financial Reporting Issues - On February 5, 2026, Hub Group filed a Current Report with the SEC, revealing an error that led to the understatement of purchased transportation costs and accounts payable for the first nine months of 2025 [3]. - As a result of this error, Hub Group plans to restate its financial statements for the first three quarters of 2025 [3]. - Following the announcement, Hub Group's stock price dropped by $9.37 per share, or 18.3%, closing at $41.96 per share on February 6, 2026 [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements for investors, including the largest securities class action settlement against a Chinese company and has been consistently ranked among the top firms for securities class action settlements [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering substantial amounts for its clients [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Ultragenyx Pharmaceutical Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Ultragenyx common stock between August 3, 2023, and December 26, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by April 6, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [7]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. - The firm has been recognized for its achievements in securities class action settlements, including a notable settlement against a Chinese company and ranking highly in the number of settlements since 2013 [4]. Group 3: Case Background - The lawsuit alleges that Ultragenyx's management provided misleading information regarding the efficacy of setrusumab (UX 143) in clinical trials for Osteogenesis Imperfecta, leading to inflated stock prices [5][6]. - It is claimed that while setrusumab increased bone density, it did not correlate with a decrease in fracture rates, contrary to management's assertions [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Paysafe Limited securities between March 4, 2025, and November 12, 2025, of the upcoming lead plaintiff deadline on April 7, 2026, for a class action lawsuit related to misleading statements made by the company [1]. Group 1: Class Action Details - Investors who bought Paysafe securities during the specified class period may be eligible for compensation without any out-of-pocket costs through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by April 7, 2026 [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against Paysafe - The lawsuit alleges that Paysafe made false or misleading statements and failed to disclose significant risks, including exposure to a high-risk client and understated credit loss reserves [4]. - It is claimed that these issues negatively impacted Paysafe's revenue growth and overall financial guidance for fiscal year 2025 [4]. - The misleading statements made by Paysafe's management are said to have caused investor damages when the true information became public [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of KDDI Corporation due to allegations of materially misleading business information issued by KDDI [1]. Group 1: Investigation and Allegations - KDDI Corporation is facing an investigation for potentially misleading business information that may have affected investors [1]. - The firm is preparing a class action to seek recovery of investor losses, allowing affected shareholders to join without any out-of-pocket fees [2]. Group 2: Company Announcement and Market Reaction - On February 6, 2026, KDDI announced a postponement of its earnings report disclosure, citing uncertainties related to quarterly results and an internal investigation [3]. - Following this announcement, KDDI's American Depositary Receipts (ticker symbol "KDDIY") experienced a significant decline of 11.4% on the same day [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering substantial amounts for its clients [5].

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2026. SO WHAT: If you purchased REGENXBIO securities during the Class Period you may be enti ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Paysafe Limited securities between March 4, 2025, and November 12, 2025, of the April 7, 2026, deadline to serve as lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Paysafe securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by April 7, 2026, to serve as lead plaintiff [2] - The lawsuit alleges that Paysafe made false or misleading statements and failed to disclose significant risks related to its ecommerce business, which could materially impact revenue growth and financial guidance for fiscal year 2025 [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability and experience in handling such cases [3]

Core Viewpoint - Rosen Law Firm is reminding sellers of Endeavor Group Holdings, Inc. Class A common stock about a class action lawsuit and the upcoming lead plaintiff deadline on March 18, 2026 [1]. Group 1: Class Action Details - Investors who sold Endeavor Class A common stock between January 15, 2025, and March 24, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by March 18, 2026 [3]. - The lawsuit seeks to recover damages for investors due to allegedly false and misleading statements in the January 15, 2025 Information Statement and related SEC filings [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The complaint alleges that the Information Statement misled investors regarding the true value of Endeavor's shares and failed to disclose executive earnings and conflicts of interest related to the merger [5].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Allegations - GSI Technology may have misled investors regarding its chip capabilities, specifically that it did not run the Gemma-3 but only the pre-generation RAG phase, which is critical for AI workloads [3]. - Following the allegations, GSI Technology's stock price dropped by $1.08 per share, or 14.2%, closing at $6.52 per share on February 4, 2026 [3]. Group 2: Class Action Details - Investors who purchased GSI Technology securities may be eligible for compensation through a class action lawsuit without any out-of-pocket fees, facilitated by a contingency fee arrangement [2]. - Interested investors can join the class action by submitting a form or contacting the Rosen Law Firm directly [2]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for its clients [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Paysafe Limited securities between March 4, 2025, and November 12, 2025, of the upcoming lead plaintiff deadline for a class action lawsuit set for April 7, 2026 [1]. Group 1: Class Action Details - Investors who bought Paysafe securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by April 7, 2026 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that Paysafe made false or misleading statements regarding its ecommerce business, which had significant exposure to a high-risk client, leading to understated credit loss reserves [4]. - It is claimed that these issues negatively impacted Paysafe's revenue growth and that the company was unlikely to meet its previously issued financial guidance for fiscal year 2025 [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Nidec Corporation due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Allegations - Nidec Corporation is facing scrutiny after a report indicated that its shares dropped 22% following the announcement of a probe into improper accounting practices within its group [3]. - The investigation stems from allegations that Nidec may have misled investors regarding its financial status, which has led to significant losses for shareholders [1][3]. Group 2: Class Action and Compensation - Shareholders who purchased Nidec securities may be eligible for compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2]. - The Rosen Law Firm is preparing to file a class action to recover losses incurred by investors as a result of the alleged misleading information [2]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability and experience in handling such cases [4].